SHELL ASSET MANAGEMENT CO - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$256,000
+23.7%
5,9150.0%0.01%0.0%
Q3 2020$207,000
-34.5%
5,9150.0%0.01%
-37.5%
Q2 2020$316,000
+48.4%
5,915
-1.3%
0.01%
+33.3%
Q1 2020$213,000
-26.6%
5,991
-1.5%
0.01%0.0%
Q4 2019$290,000
+43.6%
6,082
-2.3%
0.01%
+20.0%
Q3 2019$202,000
-35.5%
6,225
-0.8%
0.01%
-28.6%
Q2 2019$313,000
-27.7%
6,278
-2.2%
0.01%
-30.0%
Q1 2019$433,000
+46.3%
6,4200.0%0.01%
+42.9%
Q4 2018$296,000
-44.6%
6,420
-7.2%
0.01%
-36.4%
Q3 2018$534,0006,9200.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Caligan Partners LP 514,711$22,194,3385.19%
ACUTA CAPITAL PARTNERS, LLC 78,700$3,393,5442.86%
Bellevue Group AG 3,879,548$167,286,1102.72%
Parkman Healthcare Partners LLC 446,416$19,249,4582.58%
Eagle Health Investments LP 330,830$14,265,3902.50%
SECTOR GAMMA AS 121,844$5,253,9131.96%
Frazier Life Sciences Management, L.P. 871,974$37,599,5191.76%
BVF INC/IL 1,190,107$51,317,4141.44%
Rock Springs Capital Management LP 1,044,261$45,028,5341.36%
FARALLON CAPITAL MANAGEMENT LLC 5,654,502$243,822,1261.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders